VIVORYON THERAPEUTICS N.V. |
Market Closed -
Other stock markets
|
After market 01:28:00 am | |||
| 0.753 EUR | -5.88% |
|
0.764 | +1.46% |
| 24/04 | Transcript : Vivoryon Therapeutics N.V., 2023 Earnings Call, Apr 24, 2024 | |
| 15/03 | Vivoryon Therapeutics N.V Announces Resignation of Board of Directors | CI |
Chart calendar Vivoryon Therapeutics N.V.
3ff0a82e02d848.TUKRiwpf5Qk68j_0PehbnpwpHaiLIdbj4uPW2s9wDUw.Nyja0kU8s0hehVuFDtoP9vJ9dJ_OZbmitpmyjqo_YAp4K6LScGyhPWvKVA~670c015d2b5ac5ec2069238a0d3aa43c
Upcoming events on Vivoryon Therapeutics N.V.
Past events on Vivoryon Therapeutics N.V.
| 24/04/2024 06:30 pm | Q4 2023 Earnings Call |
| 24/04/2024 10:30 am | Q4 2023 Earnings Release |
| 16/04/2024 | Van Lanschot Kempen Life Sciences Conference |
| 29/02/2024 | Investor Meeting |
| 08/01/2024 | JPMorgan Healthcare Conference |
| 06/12/2023 07:30 pm | Q3 2023 Earnings Call |
| 06/12/2023 11:30 am | Q3 2023 Earnings Release |
| 14/11/2023 05:00 pm | Jefferies London Healthcare Conference |
| 06/11/2023 | BIO Europe Conference |
| 24/10/2023 | Alzheimer Disease Conference |
| 17/10/2023 05:00 pm | R&D Day - Key Opinion Leader |
| 11/10/2023 11:30 pm | Jefferies Inaugural Biotech CNS/Neuro Summit |
| 15/09/2023 04:30 pm | Extraordinary Shareholders Meeting |
| 07/09/2023 06:30 pm | Q2 2023 Earnings Call |
| 07/09/2023 10:30 am | Q2 2023 Earnings Release |
| 16/07/2023 | Alzheimer Association International Conference |
| 21/06/2023 04:30 pm | Annual General Meeting |
| 07/06/2023 05:30 pm | Jefferies Global Healthcare Conference |
| 05/06/2023 | BIO International Convention |
| 16/05/2023 03:14 pm | BioEquity Europe Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 | 0,00 | 0,00 0,00 - | 10,8 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA Million EUR | Released Forecast Spread | -7,68 | 0,00 | -15,9 -13,2 -20.65% | -12,6 -17,7 28.63% | -29,0 -19,8 -45.96% | -28,7 -22,9 -25.2% |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | 0,00 | -16,0 -13,3 -20.84% | -12,8 -17,8 28.1% | -29,1 -20,3 -43.25% | -28,8 -23,0 -25.38% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | 0,00 | -16,5 -13,3 -24.14% | -12,2 -18,3 33.21% | -28,4 -20,3 -39.75% | -28,6 -23,0 -24.24% |
|
Net income Million EUR | Released Forecast Spread | -7,74 | -7,82 | -16,5 -13,3 -24.14% | -12,7 -18,3 30.85% | -28,2 -19,3 -46.21% | -28,3 -23,0 -23.23% |
|
EPS EUR | Released Forecast Spread | -0,94 | -0,62 | -0,83 -0,67 -24.81% | -0,63 -0,92 31.52% | -1,28 -0,85 -50.59% | -1,12 -0,93 -20.43% |
| Announcement Date | 28/03/19 | 26/03/20 | 30/04/21 | 28/04/22 | 19/04/23 | 24/04/24 |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2023 S1 | 2023 S2 |
|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | |
|
EBIT Million EUR | Released Forecast Spread | -3,08 -2,24 -37.67% | -18,1 -12,6 -44.01% | |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -17,8 -13,0 -37.04% | ||
|
Net income Million EUR | Released Forecast Spread | -10,7 | -17,6 -13,1 -34.55% | |
|
EPS EUR | Released Forecast Spread | -0,44 | -0,68 -0,50 -36% | |
| Announcement Date | 30/07/19 | 07/09/23 | 24/04/24 |
| 30/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Vivoryon Therapeutics N.V.
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VVY Stock
- Calendar Vivoryon Therapeutics N.V.
